Education
About Us
Working with TipRanks
Follow Us
Eris Lifesciences Ltd (IN:ERIS)
:ERIS
Total Valuation
Eris Lifesciences Ltd has a market cap or net worth of ₹244.34B. The enterprise value is ―.
Market Cap₹244.34B
Enterprise Value―
Share Statistics
Eris Lifesciences Ltd has 136,197,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding136,197,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eris Lifesciences Ltd’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count3,620
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio69.4
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Eris Lifesciences Ltd had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Eris Lifesciences Ltd pays an annual dividend of ₹7.349, resulting in a dividend yield of 0.41%
Dividend Per Share₹7.349
Dividend Yield0.41%
Payout Ratio28.49%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change58.62%
50-Day Moving Average1.67K
200-Day Moving Average1.43K
Relative Strength Index (RSI)63.10
Average Volume (3m)7.38K
Important Dates
Eris Lifesciences Ltd upcoming earnings date is Aug 12, 2025, TBA (Confirmed).
Last Earnings DateMay 19, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend DateFeb 13, 2025
Financial Position
Eris Lifesciences Ltd as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Eris Lifesciences Ltd has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Eris Lifesciences Ltd EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Eris Lifesciences Ltd has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Eris Lifesciences Ltd is ₹1,880.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,880.00
Price Target Upside4.79% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast44.02%
EPS Growth Forecast-10.20%